Antibiotic bactericides [Group 24 and Group 25] resistance management strategy

Fire blight Erwinia amylovora on pear shoots
(Photo: J.L. Vanneste)
Updated 2023, R. Beresford and M. Christie
Introduction
The purpose of this guideline is to help maximise the useful life of fungicides in the Fungicide Resistance Action Committee (FRAC) Group 9 for controlling plant diseases in New Zealand by providing relevant information about the nature of pathogen resistance to this group and guidance on practices that may prevent or reduce the development of resistance.
Disclaimer:
The fungicide and bactericide resistance information in the mode of action group table, the mode of action-based strategies and the crop-based strategies is intended to help manage the effects of pesticide resistance on plant disease control by agrochemicals in New Zealand. The New Zealand Committee on Pesticide Resistance (NZCPR) is a subcommittee of the New Zealand Plant Protection Society (NZPPS). The following parties: NZCPR, NZPPS, any people named in the strategies and any organisation the people may be affiliated with, do not guarantee that the resistance information is complete, consistent, accurate or up-to-date, or that resistance will not develop, or that the degree of resistance will decrease, as a result of the resistance information being used, and the parties accept no liability for loss or damage arising from the use of the resistance information contained in these strategies.
Antibiotic product perspective
Two antibiotics, often referred to as aminoglycoside antibiotics (AGAs), are used against bacterial plant pathogens in New Zealand. These are: 1) streptomycin, classified by FRAC (the Fungicide Resistance Action Committee) as a Group 25 glucopyranosyl antibiotic, and 2) kasugamycin, classified by FRAC as a Group 24 hexopyranosyl antibiotic. Group 24 and 25 antibiotics both inhibit amino acid and protein synthesis in bacterial plant pathogens. One streptomycin product (Keystrepto™) and one kasugamycin product (Kasumin™) are registered for use in New Zealand on plants by The Agricultural Compounds and Veterinary Medicines Group (ACVM) of the Ministry for Primary Industries (MPI) (Table 1).
| Pathogen | Disease | Crop |
|---|---|---|
| 1. Streptomycin | ||
| Erwinia amylovora | fire blight | Apple, pear and nashi |
| Pseudomonas syringae pv. syringae | bacterial blast | Stonefruit |
| Xanthomonas arboricola pv. pruni | bacterial spot | Stonefruit |
| Pseudomonas syringae pv. tomato | tomato speck | Seedling tomatoes |
| Pseudomonas syringae pv. syringae | Seedling tomatoes | |
| Xanthomonas campestris pv. vesicatoria | bacterial spot | Seedling tomatoes |
| Clavibacter michiganensis pv. michiganensis | bacterial canker and wilt | Seedling tomatoes |
| Pseudomonas syringae pv. actinidiae | PSA-V (bacterial canker) | Kiwifruit |
| 2. Kasugamycin | ||
| Pseudomonas syringae pv. actinidiae | PSA-V (bacterial canker) | Kiwifruit |
Current status of antibiotic resistance
The FRAC classification for streptomycin resistance risk is ‘high’ and for kasugamycin the risk is ‘medium’, and resistance management is required for both these antibiotics. There is no cross-resistance between streptomycin and kasugamycin.
Streptomycin binds to the bacterial ribosome, interfering with peptide synthesis. Resistance can result from either a modification of the ribosome or a modification of the antibiotic itself. Streptomycin is used in veterinary medicine as well as for plant protection. Resistance to streptomycin appears to be relatively common and has been reported in plant pathogens and other plant-associated bacteria both in New Zealand and overseas. It seems the presence of streptomycin-resistant strains in bacterial plant pathogen populations does not necessarily compromise disease control.
Kasugamycin is used only in plants, not in human nor veterinary medicine(Verhaegen et al. 2023). Resistance to kasugamycin in plant pathogens is known internationally but does not appear to be associated with major disease control problems. Kasugamycin resistance has not been studied in New Zealand.
Resistance management strategy
See Table 2 for resistance management recommendations on antibiotic bactericide use in specific crops. In general, antibiotic bactericides should only be applied when weather conditions are favourable for disease development, the target pathogen is present and disease has not yet developed. Do not use for emergency disease management during a severe disease outbreak. When other compounds are available, they should be used in preference to antibiotic bactericides.
At the first sign of lack of efficacy in one of these antibiotics, or if resistance has been previously detected onsite, their use should be suspended until the presence or absence of resistant strains of the pathogen can be confirmed. (Streptomycin-resistant strains of bacterial plant pathogens can survive a long time.) Since antibiotics could kill epiphytic bacteria that would compete with the pathogen for space and nutrients (and therefore may reduce disease severity), the use of antibiotics on crops infected by antibiotic-resistant strains of a bacterial pathogen could actually increase disease development.
| Crop | Disease | Recommendations |
|---|---|---|
| 1. Streptomycin | ||
| Apples, pears | Fire blight |
|
| Stonefruit | Bacterial blast and bacterial spot |
|
| Tomato seedlings | Bacterial speck, spot, canker and wilt |
|
| Kiwifruit | Psa-V (bacterial canker) |
|
| 2. Kasugamycin | ||
| Kiwifruit | Psa-V (bacterial canker) |
|
Recommendations on implementation of this strategy
Label directions for the use of antibiotic bactericides should include an appropriate statement about resistance management and recommendations about the maximum number of applications that should be applied each year.
Acknowledgements
This resistance management strategy has been updated from the original streptomycin strategy prepared by J.L. Vanneste in 2011.
References
Verhaegen M, Bergot T, Liebana E, Stancanelli G, Streissl F, Mingeot-Leclercq MP, Mahillon J, Bragard C 2023. On the use of antibiotics to control plant pathogenic bacteria: a genetic and genomic perspective. Front Microbiol. 2023 Jun 27;14:1221478. doi: 10.3389/fmicb.2023.1221478. PMID: 37440885; PMCID: PMC10333595.




© 2026 New Zealand Plant Protection Society (Incorporated). All rights reserved.